Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Intermezzo, zolpidem
print preview
bookmark
share with colleague
General Information
Company
Transcept Pharmaceuticals Inc.
Description
Low-dose sublingual formulation of zolpidem
Molecular Target
GABA A receptor
Mechanism of Action
GABA A receptor modulator
Latest Stage of Development
Marketed
Indication
Insomnia
Partner
Purdue Pharma L.P.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information